Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1978 Dec;188(6):758–768. doi: 10.1097/00000658-197812000-00008

Alterations in Plasma Norepinephrine Concentration During Surgical Resection of Pheochromocytoma

Jerome M Feldman, Judith A Blalock, Lennart Fagraeus, John N Miller, Ruth E Farrell, Samuel A Wells Jr
PMCID: PMC1396999  PMID: 570022

Abstract

Using a sensitive and specific radioenzymatic assay, the plasma norepinephrine (NE) concentration was measured in seven patients with pheochromocytoma, one patient with bilateral adrenal medullary hyperplasia, one patient with a retroperitoneal paraganglioma, and two patients undergoing bilateral adrenalectomies for palliation of metastatic breast carcinoma. Surgical manipulation of the pheochromocytomas resulted in striking increases in plasma NE concentration with concomitant increases in blood pressure. There were either small changes or no changes in the patients' plasma NE and blood pressure during resection of the normal adrenal glands, the adrenal glands with medullary hyperplasia, or the retroperitoneal paraganglioma. Plasma dopamine-β-hydroxylase (DBH) was measured in one patient with pheochromocytomas and the patient with medullary hyperplasia. There was no change in plasma DBH in either patient, supporting the concept that exocytosis is not the primary mechanism for catecholamine secretion from pheochromocytomas. It was also noted that enflurane is an excellent general anesthetic for the resection of pheochromocytomas, and that sodium nitroprusside (rather than phentolamine) may be the agent of choice for the management of the hypertensive episodes that occur during surgical manipulation of pheochromocytomas.

Full text

PDF
758

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962 Dec;138:360–375. [PubMed] [Google Scholar]
  2. APGAR V., PAPPER E. M. Pheochromocytoma. Anesthetic management during surgical treatment. AMA Arch Surg. 1951 May;62(5):634–648. [PubMed] [Google Scholar]
  3. Carney J. A., Sizemore G. W., Sheps S. G. Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors. Am J Clin Pathol. 1976 Aug;66(2):279–290. doi: 10.1093/ajcp/66.2.279. [DOI] [PubMed] [Google Scholar]
  4. Cooperman L. H., Engelman K., Mann P. E. Anesthetic management of pheochromocytoma employing halothane and beta adrenergic blockade. A report of fourteen cases. Anesthesiology. 1967 May-Jun;28(3):575–582. [PubMed] [Google Scholar]
  5. ETSTEN B. E., SHIMOSATO S. HALOTHANE ANESTHESIA AND CATECHOLAMINE LEVELS IN A PATIENT WITH PHEOCHROMOCYTOMA. Anesthesiology. 1965 Sep-Oct;26:688–691. doi: 10.1097/00000542-196509000-00022. [DOI] [PubMed] [Google Scholar]
  6. El-Naggar M., Suerte E., Rosenthal E. Sodium nitroprusside and lidocaine in the anaesthetic management of pheochromocytoma. Can Anaesth Soc J. 1977 May;24(3):353–360. doi: 10.1007/BF03005108. [DOI] [PubMed] [Google Scholar]
  7. Gewirtz G. P., Kopin I. J. Release of dopamine-beta-hydroxylase with norepinephrine during cat splenic nerve stimulation. Nature. 1970 Jul 25;227(5256):406–407. doi: 10.1038/227406a0. [DOI] [PubMed] [Google Scholar]
  8. Harrison T. S., Bartlett J. D., Jr, Seaton J. F. Current evaluation and management of pheochromocytoma. Ann Surg. 1968 Oct;168(4):701–713. doi: 10.1097/00000658-196810000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henry D. P., Starman B. J., Johnson D. G., Williams R. H. A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Life Sci. 1975 Feb 1;16(3):375–384. doi: 10.1016/0024-3205(75)90258-1. [DOI] [PubMed] [Google Scholar]
  10. Johnston R. R., Eger EI I. I., Wilson C. A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man. Anesth Analg. 1976 Sep-Oct;55(5):709–712. doi: 10.1213/00000539-197609000-00021. [DOI] [PubMed] [Google Scholar]
  11. Kreul J. F., Dauchot P. J., Anton A. H. Hemodynamic and catecholamine studies during pheochromocytoma resection under enflurane anesthesia. Anesthesiology. 1976 Mar;44(3):265–268. doi: 10.1097/00000542-197603000-00022. [DOI] [PubMed] [Google Scholar]
  12. Kuzuya H., Nagatsu T. A simple assay of dopamine beta-hydroxylase activity in the homogenate of the adrenal medulla. Enzymologia. 1969 Jan 31;36(1):31–38. [PubMed] [Google Scholar]
  13. Mazze R. I., Trudell J. R., Cousins M. J. Methoxyflurane metabolism and renal dysfunction: clinical correlation in man. Anesthesiology. 1971 Sep;35(3):247–252. doi: 10.1097/00000542-197109000-00004. [DOI] [PubMed] [Google Scholar]
  14. NOUROK D. S., GWINUP G., HAMWI G. J. Phentolamine-resistant pheochromocytoma treated with sodium nitroprusside. JAMA. 1963 Mar 9;183:841–844. doi: 10.1001/jama.1963.03700100067011. [DOI] [PubMed] [Google Scholar]
  15. Nagatsu T., Udenfriend S. Photometric assay of dopamine- -hydroxylase activity in human blood. Clin Chem. 1972 Sep;18(9):980–983. [PubMed] [Google Scholar]
  16. Ortiz F. T., Diaz P. M. Use of enflurane for pheochromocytoma removal. Anesthesiology. 1975 Apr;42(4):495–497. doi: 10.1097/00000542-197504000-00024. [DOI] [PubMed] [Google Scholar]
  17. PISANO J. J. A simple analysis for normetanephrine and metanephrine in urine. Clin Chim Acta. 1960 May;5:406–414. doi: 10.1016/0009-8981(60)90146-7. [DOI] [PubMed] [Google Scholar]
  18. PISANO J. J., CROUT J. R., ABRAHAM D. Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clin Chim Acta. 1962 Mar;7:285–291. doi: 10.1016/0009-8981(62)90022-0. [DOI] [PubMed] [Google Scholar]
  19. Remine W. H., Chong G. C., Van Heerden J. A., Sheps S. G., Harrison E. G., Jr Current management of pheochromocytoma. Ann Surg. 1974 May;179(5):740–748. doi: 10.1097/00000658-197405000-00029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SANKOFF I., SOURKES T. L. Determination by thin-layer chromatography of urinary homovanillic acid in normal and disease states. Can J Biochem Physiol. 1963 Jun;41:1381–1388. [PubMed] [Google Scholar]
  21. Steiner A. L., Goodman A. D., Powers S. R. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2. Medicine (Baltimore) 1968 Sep;47(5):371–409. doi: 10.1097/00005792-196809000-00001. [DOI] [PubMed] [Google Scholar]
  22. VON EULER U. S., FLODING I. Fluorimetric estimation of noradrenaline and adrenaline in urine. Acta Physiol Scand Suppl. 1955;33(118):57–62. [PubMed] [Google Scholar]
  23. Weinshilboum R., Axelrod J. Serum dopamine-beta-hydroxylase activity. Circ Res. 1971 Mar;28(3):307–315. doi: 10.1161/01.res.28.3.307. [DOI] [PubMed] [Google Scholar]
  24. Wells S. A., Jr, Baylin S. B., Linehan W. M., Farrell R. E., Cox E. B., Cooper C. W. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg. 1978 Aug;188(2):139–141. doi: 10.1097/00000658-197808000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES